Product Code: ETC6187499 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
This market encompasses a wide range of therapeutic interventions beyond pharmacological solutions, including physical therapy, nerve blocks, and complementary treatments such as acupuncture and cognitive behavioral therapy. The rising demand for non-opioid alternatives, driven by concerns over opioid addiction and side effects, is fostering innovation in therapeutic approaches. Healthcare infrastructure expansion and increasing geriatric population contribute to sustained demand.
Therapeutics for pain management in Australia are evolving with a shift toward multidisciplinary approaches combining pharmacological and non-pharmacological treatments. There is increased research into biologics, nerve stimulation therapies, and regenerative medicine options. Telemedicine and digital health platforms for pain therapy management are gaining traction, improving patient adherence and monitoring. Moreover, the market is expanding due to aging demographics and rising incidence of post-surgical and chronic pain conditions.
This market contends with the complexity of treating chronic pain, which often involves a combination of physical, psychological, and pharmacological interventions. Integration of multidisciplinary care models remains limited, and reimbursement policies are fragmented. The stigma around mental health and pain further restricts the adoption of holistic therapeutic approaches, leading to under-treatment or mismanagement in many cases.
Non-pharmacological pain therapies like physiotherapy, TENS (transcutaneous electrical nerve stimulation), acupuncture, and cognitive behavioral therapy are gaining traction in Australia. Investors can explore partnerships with health clinics or tech-driven pain management platforms offering integrated solutions. The shift towards holistic treatment and mental health integration opens avenues for scalable and sustainable therapeutic models.
In the therapeutics space, Australias healthcare policies support a multidisciplinary approach to pain management. The National Strategic Framework for Chronic Conditions emphasizes integrated care models, funding for pain clinics, and public awareness campaigns. Government grants also support research into non-opioid alternatives and complementary therapies, aligning with broader public health goals to reduce opioid dependency and enhance quality of life.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pain Management Therapeutics Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pain Management Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Pain Management Therapeutics Market - Industry Life Cycle |
3.4 Australia Pain Management Therapeutics Market - Porter's Five Forces |
3.5 Australia Pain Management Therapeutics Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
4 Australia Pain Management Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Pain Management Therapeutics Market Trends |
6 Australia Pain Management Therapeutics Market, By Types |
6.1 Australia Pain Management Therapeutics Market, By Therapeutics |
6.1.1 Overview and Analysis |
6.1.2 Australia Pain Management Therapeutics Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.1.3 Australia Pain Management Therapeutics Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.1.4 Australia Pain Management Therapeutics Market Revenues & Volume, By Antidepressants, 2021- 2031F |
6.1.5 Australia Pain Management Therapeutics Market Revenues & Volume, By Anesthetics, 2021- 2031F |
6.1.6 Australia Pain Management Therapeutics Market Revenues & Volume, By Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2021- 2031F |
6.1.7 Australia Pain Management Therapeutics Market Revenues & Volume, By Opioids, 2021- 2031F |
6.1.8 Australia Pain Management Therapeutics Market Revenues & Volume, By Antimigraine Agents, 2021- 2031F |
7 Australia Pain Management Therapeutics Market Import-Export Trade Statistics |
7.1 Australia Pain Management Therapeutics Market Export to Major Countries |
7.2 Australia Pain Management Therapeutics Market Imports from Major Countries |
8 Australia Pain Management Therapeutics Market Key Performance Indicators |
9 Australia Pain Management Therapeutics Market - Opportunity Assessment |
9.1 Australia Pain Management Therapeutics Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
10 Australia Pain Management Therapeutics Market - Competitive Landscape |
10.1 Australia Pain Management Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Australia Pain Management Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |